Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Shi M;Shi M; Ma Y; Ma Y; Li H; Li H; Li F; Li F; Shen S; Shen S
  • Source:
    Journal of pharmacy practice [J Pharm Pract] 2025 Feb; Vol. 38 (1), pp. 74-80. Date of Electronic Publication: 2024 Aug 06.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-1937 (Electronic) Linking ISSN: 08971900 NLM ISO Abbreviation: J Pharm Pract Subsets: MEDLINE
    • Publication Information:
      Publication: <2002-> : Thousand Oaks, Calif. : Sage Publications
      Original Publication: [Philadelphia, PA] : W.B. Saunders, [1988]-
    • Subject Terms:
      Psychotropic Drugs*/classification ; Psychotropic Drugs*/therapeutic use ; Drug-Related Side Effects and Adverse Reactions*/prevention & control; Humans ; Male ; Europe ; Female ; Middle Aged ; Adult ; Pharmacists ; Mental Disorders/drug therapy ; Mental Disorders/classification ; Pharmacy Service, Hospital/organization & administration ; Aged ; Pharmaceutical Services/organization & administration
    • Abstract:
      This research aims to summarize and discuss issues related to psychiatric drugs by using the classification system of the Pharmaceutical Care Network Europe (PCNE) and to provide a reference for the development and direction of clinical pharmacists' work in the future. Psychiatric patients who were hospitalized in our hospital from Janurary 2023 to December 2023 were enrolled. Drug-related problems (DRPs) were evaluated using the PCNE classification system (version 9.0). The types, causes, intervention plans, acceptance of intervention plans, and statuses of DRPs were analyzed. A total of 362 patients were included, covering 405 DRP cases, with an average DRP of 1.12 for each patient. All 405 DRP cases underwent interventions, with a success rate of 83.46%. The main categories of related drugs were psychotropic drugs (70.37%), anti-infective drugs (8.89%), and cardiovascular system drugs (5.19%). The main DRPs were possible adverse drug events (21.24%), poor treatment effects (69.14%), and unnecessary medication treatment (9.63%). The main causes of DRPs were inappropriate drug selection (18.52%), inappropriate combinations of drugs (16.05%), and excessive drug dosage (13.58%). The PCNE classification system helps clinical pharmacists improve their ability to identify and solve DRPs faced by psychiatric departments, improve pharmaceutical care efficiency, and ensure rational drug use.
      Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
    • Contributed Indexing:
      Keywords: clinical pharmacist; drug-related problem; pharmaceutical care network Europe classification system; psychiatric department; rational drug use
    • Accession Number:
      0 (Psychotropic Drugs)
    • Publication Date:
      Date Created: 20240806 Date Completed: 20241212 Latest Revision: 20241212
    • Publication Date:
      20241212
    • Accession Number:
      10.1177/08971900241273200
    • Accession Number:
      39107890